DEFA14A: SpringWorks Therapeutics Sets Date for 2025 Annual Stockholder Meeting

SpringWorks Therapeutics will hold its annual stockholder meeting virtually on May 14, 2025, to vote on director elections, auditor ratification, and executive compensation.

Summary

• SpringWorks Therapeutics will hold its 2025 Annual Meeting of Stockholders on May 14, 2025, at 10:00 A.M. Eastern Time, virtually.
• Stockholders can access meeting materials and vote online at www.investorvote.com/SWTX.
• The meeting will include voting on the election of three Class III Directors: Alan Fuhrman, Julie Hambleton, M.D., and Daniel S. Lynch, M.B.A.
• Stockholders will also vote to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• A non-binding advisory vote on executive compensation is also scheduled.
• The Board of Directors recommends voting FOR all director nominees and FOR Proposals 2 and 3.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an upcoming shareholder meeting, which is generally neutral to positive as it reflects corporate governance processes.

Positives

• The meeting is being held virtually, providing convenient access for stockholders.
• Stockholders have multiple options to access proxy materials and vote, including online, phone, and email.
• The board is providing clear recommendations on how to vote on each proposal.

Future Outlook

The document outlines the agenda for the upcoming annual meeting, focusing on corporate governance matters such as director elections and auditor ratification.

Industry Context

This announcement is standard practice for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions regarding the company's governance.

Stakeholder Impact

• Shareholders have the opportunity to vote on key company matters.
• The outcome of the votes will influence the composition of the board and the selection of the company's auditor.

Next Steps

• Stockholders should review the proxy materials.
• Stockholders should vote on the proposals before the meeting.
• Stockholders can attend the virtual annual meeting on May 14, 2025.

Key Dates

Keywords

Stockholder Meeting, Proxy Statement, Annual Meeting, SpringWorks Therapeutics, Voting, Directors, Executive Compensation, Auditor, Ernst & Young